These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22915638)

  • 1. Inhibition of hedgehog signaling for the treatment of murine sclerodermatous chronic graft-versus-host disease.
    Zerr P; Palumbo-Zerr K; Distler A; Tomcik M; Vollath S; Munoz LE; Beyer C; Dees C; Egberts F; Tinazzi I; Del Galdo F; Distler O; Schett G; Spriewald BM; Distler JH
    Blood; 2012 Oct; 120(14):2909-17. PubMed ID: 22915638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of canonical WNT signaling ameliorates experimental sclerodermatous chronic graft-versus-host disease.
    Zhang Y; Shen L; Dreißigacker K; Zhu H; Trinh-Minh T; Meng X; Tran-Manh C; Dees C; Matei AE; Chen CW; Ditschkowski M; Krauss S; Winkler J; Wolff D; Ziemer M; Beilhack A; Karrer S; Herr W; Mackensen A; Schett G; Spriewald BM; Distler JHW
    Blood; 2021 Apr; 137(17):2403-2416. PubMed ID: 33529322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined inhibition of c-Abl and PDGF receptors for prevention and treatment of murine sclerodermatous chronic graft-versus-host disease.
    Zerr P; Distler A; Palumbo-Zerr K; Tomcik M; Vollath S; Dees C; Egberts F; Tinazzi I; Del Galdo F; Distler O; Schett G; Spriewald BM; Distler JH
    Am J Pathol; 2012 Nov; 181(5):1672-80. PubMed ID: 22940072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of hedgehog signalling prevents experimental fibrosis and induces regression of established fibrosis.
    Horn A; Kireva T; Palumbo-Zerr K; Dees C; Tomcik M; Cordazzo C; Zerr P; Akhmetshina A; Ruat M; Distler O; Beyer C; Schett G; Distler JH
    Ann Rheum Dis; 2012 May; 71(5):785-9. PubMed ID: 22402139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of p38 Mitogen-Activated Protein Kinase Inhibits Murine Sclerodermatous Chronic Graft-versus-Host Disease.
    Matsushita T; Date M; Kano M; Mizumaki K; Tennichi M; Kobayashi T; Hamaguchi Y; Hasegawa M; Fujimoto M; Takehara K
    Am J Pathol; 2017 Apr; 187(4):841-850. PubMed ID: 28189565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease.
    Le Huu D; Matsushita T; Jin G; Hamaguchi Y; Hasegawa M; Takehara K; Tedder TF; Fujimoto M
    Blood; 2013 Apr; 121(16):3274-83. PubMed ID: 23422748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation.
    Zhang Y; McCormick LL; Desai SR; Wu C; Gilliam AC
    J Immunol; 2002 Mar; 168(6):3088-98. PubMed ID: 11884483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the hedgehog-glioma-associated oncogene homolog pathway inhibits bleomycin-induced lung fibrosis in mice.
    Moshai EF; Wémeau-Stervinou L; Cigna N; Brayer S; Sommé JM; Crestani B; Mailleux AA
    Am J Respir Cell Mol Biol; 2014 Jul; 51(1):11-25. PubMed ID: 24450438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-6 blockade attenuates the development of murine sclerodermatous chronic graft-versus-host disease.
    Le Huu D; Matsushita T; Jin G; Hamaguchi Y; Hasegawa M; Takehara K; Fujimoto M
    J Invest Dermatol; 2012 Dec; 132(12):2752-61. PubMed ID: 22810302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of the hedgehog pathway inhibits osteophyte formation in arthritis.
    Ruiz-Heiland G; Horn A; Zerr P; Hofstetter W; Baum W; Stock M; Distler JH; Nimmerjahn F; Schett G; Zwerina J
    Ann Rheum Dis; 2012 Mar; 71(3):400-7. PubMed ID: 22233602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis.
    Horn A; Palumbo K; Cordazzo C; Dees C; Akhmetshina A; Tomcik M; Zerr P; Avouac J; Gusinde J; Zwerina J; Roudaut H; Traiffort E; Ruat M; Distler O; Schett G; Distler JH
    Arthritis Rheum; 2012 Aug; 64(8):2724-33. PubMed ID: 22354771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcription factor GLI2 as a downstream mediator of transforming growth factor-β-induced fibroblast activation in SSc.
    Liang R; Šumová B; Cordazzo C; Mallano T; Zhang Y; Wohlfahrt T; Dees C; Ramming A; Krasowska D; Michalska-Jakubus M; Distler O; Schett G; Šenolt L; Distler JH
    Ann Rheum Dis; 2017 Apr; 76(4):756-764. PubMed ID: 27793816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of smoothened activates the sonic hedgehog signaling pathway in pancreatic cancer-associated fibroblasts.
    Walter K; Omura N; Hong SM; Griffith M; Vincent A; Borges M; Goggins M
    Clin Cancer Res; 2010 Mar; 16(6):1781-9. PubMed ID: 20215540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.
    You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting hedgehog signaling pathway in pediatric tumors: in vitro evaluation of SMO and GLI inhibitors.
    Arnhold V; Boos J; Lanvers-Kaminsky C
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):495-505. PubMed ID: 26781311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of Syk ameliorates the development of murine sclerodermatous chronic graft-versus-host disease.
    Le Huu D; Kimura H; Date M; Hamaguchi Y; Hasegawa M; Hau KT; Fujimoto M; Takehara K; Matsushita T
    J Dermatol Sci; 2014 Jun; 74(3):214-21. PubMed ID: 24679982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of murine sclerodermatous models by the selective S1P
    Kano M; Kobayashi T; Date M; Tennichi M; Hamaguchi Y; Strasser DS; Takehara K; Matsushita T
    Sci Rep; 2019 Jan; 9(1):658. PubMed ID: 30679645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hedgehog inhibition with the orally bioavailable Smo antagonist LDE225 represses tumor growth and prolongs survival in a transgenic mouse model of islet cell neoplasms.
    Fendrich V; Wiese D; Waldmann J; Lauth M; Heverhagen AE; Rehm J; Bartsch DK
    Ann Surg; 2011 Nov; 254(5):818-23; discussion 823. PubMed ID: 22042473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo.
    Wickström M; Dyberg C; Shimokawa T; Milosevic J; Baryawno N; Fuskevåg OM; Larsson R; Kogner P; Zaphiropoulos PG; Johnsen JI
    Int J Cancer; 2013 Apr; 132(7):1516-24. PubMed ID: 22949014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Bcl-6 prevents sclerodermatous chronic graft-versus-host disease by abrogating T follicular helper differentiation in mice.
    Chen X; Wang Y; Huang X; Geng S; Li C; Zeng L; Huang L; Du X; Weng J; Lai P
    Int Immunopharmacol; 2023 Apr; 117():109746. PubMed ID: 36827923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.